OS Therapies files to sell 10.83M shares of common stock for holders
PremiumThe FlyOS Therapies files to sell 10.83M shares of common stock for holders
2M ago
OS Therapies Inc trading resumes
Premium
The Fly
OS Therapies Inc trading resumes
2M ago
OS Therapies to acquire listeria programs from Ayala Pharmaceuticals
Premium
The Fly
OS Therapies to acquire listeria programs from Ayala Pharmaceuticals
2M ago
OS Therapies to sell 1.5M units at $4.00 in private placement
PremiumThe FlyOS Therapies to sell 1.5M units at $4.00 in private placement
3M ago
OS Therapies initiated with a Buy at Maxim
Premium
The Fly
OS Therapies initiated with a Buy at Maxim
4M ago
OS Therapies files to sell $15M in common stock for holders
Premium
The Fly
OS Therapies files to sell $15M in common stock for holders
5M ago
OS Therapies initiated with a Buy at EF Hutton
PremiumThe FlyOS Therapies initiated with a Buy at EF Hutton
7M ago
OS Therapies: Last patient in OST-HER2  Osteosarcoma trial gest last dose
Premium
The Fly
OS Therapies: Last patient in OST-HER2 Osteosarcoma trial gest last dose
7M ago
OS Therapies initiated with a Buy at Brookline
Premium
The Fly
OS Therapies initiated with a Buy at Brookline
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100